As of 2025-05-18, the Fair Value of Med BioGene Inc (MBI.H.V) is -0.02 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.02 CAD, the upside of Med BioGene Inc is -259.10%.
With the market price of 0.02 CAD and our fair value calculation, Med BioGene Inc (MBI.H.V) is not a good investment. Investing in MBI.H.V stocks now will result in a potential loss of 259.10%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -0.06 | -0.05 | -0.06 | -0.06 | -0.06 | -0.06 |
| YoY growth | -20.00% | 16.67% | -20.00% | -5.10% | 7.85% | -4.12% |
| Market Cap (mil) | 0.23 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | -4.12% |
| TTM earnings | -0.05 |